News & Updates

Etrasimod shows promise for moderately, severely active ulcerative colitis

29 Feb 2020

Etrasimod may be a potential treatment for moderately-to-severely active ulcerative colitis, though further examinations are needed, a recent study has found.

Etrasimod shows promise for moderately, severely active ulcerative colitis

29 Feb 2020

Extensive intraoperative peritoneal lavage of no benefit for gastric cancer patients

28 Feb 2020 by

Not only does washing away free tumour cells in the peritoneum with extensive intraoperative peritoneal lavage (EIPL) during gastrectomy confer no survival benefit nor prevent disease recurrence compared with surgery alone, it may come with an increased risk of side effects, according to the phase III EXPEL* study presented at GICS 2020.

Extensive intraoperative peritoneal lavage of no benefit for gastric cancer patients

28 Feb 2020

Children with abdominal symptoms must be tested for TB, says study

28 Feb 2020 by

Physicians should consider an abdominal tuberculosis (TB) diagnosis in children presenting with abdominal and constitutional symptoms, argues a recent Singapore study.

Children with abdominal symptoms must be tested for TB, says study

28 Feb 2020

Targeted combo therapies improve QoL, atop survival benefit for patients with BRAF+ CRC

27 Feb 2020 by

In addition to survival benefit, the BEACON CRC trial has now shown that a targeted drug combination of encorafenib plus cetuximab with or without binimetinib led to longer maintenance of quality of life (QoL) for patients with BRAF V600E metastatic colorectal cancer (mCRC) compared with standard chemotherapy.

Targeted combo therapies improve QoL, atop survival benefit for patients with BRAF+ CRC

27 Feb 2020

Mirikizumab shows promise in ulcerative colitis

27 Feb 2020

Mirikizumab, a monoclonal antibody targeting interleukin-23, induces clinical response in ulcerative colitis patients in 12 weeks, a recent study has found.

Mirikizumab shows promise in ulcerative colitis

27 Feb 2020

Berberine: Plant alkaloid for prevention of colorectal cancer?

26 Feb 2020 by

The plant alkaloid berberine effectively reduces the risk of recurrent colorectal adenoma in individuals who had recently undergone polypectomy, according to a study — thus providing a potential option for chemoprevention of adenoma.

Berberine: Plant alkaloid for prevention of colorectal cancer?

26 Feb 2020

Heartburn management in pregnant, lactating women begins with lifestyle changes

26 Feb 2020

Heartburn during pregnancy and lactation should be managed with lifestyle modifications, and physicians must discuss with the patient risks and benefits of medications in cases where disease severity increases, according to a recent review.

Heartburn management in pregnant, lactating women begins with lifestyle changes

26 Feb 2020

Primary tumour resection not recommended for asymptomatic advanced CRC

25 Feb 2020 by

Primary tumour resection (PTR) prior to a chemotherapy regimen does not improve survival outcomes in patients with asymptomatic unresectable stage IV colorectal cancer (CRC), according to the phase III JCOG1007* trial.